本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Arcus Biosciences Inc.

8.30
-0.1100-1.31%
盤後8.350.0500+0.60%16:27 EDT
成交量:50.37萬
成交額:415.72萬
市值:8.78億
市盈率:-2.64
高:8.34
開:8.16
低:8.07
收:8.41
資料載入中...
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/21

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/21

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report